menu_open Columnists
We use cookies to provide some features and experiences in QOSHE

More information  .  Close

The faulty forecasts of pharma firm investors: Misguided cynics miss the promising prognosis for drugmakers Pfizer and Merck

3 0
05.02.2025
Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.

© Fortune